Suppr超能文献

甲状腺功能亢进症中酮血症的调节:游离脂肪酸作用的研究

Regulation of ketonaemia in hyperthyroidism: study of the role of free fatty acids.

作者信息

Beylot M, Cohen R, Riou J P, Sautot G, Garcia I, Noel G, Mornex R

出版信息

Diabete Metab. 1983 Sep;9(3):217-23.

PMID:6360743
Abstract

We have indirectly assessed the role of free fatty acids (FFA) and of hepatic ketogenesis in the regulation of ketone body levels in euthyroid and hyperthyroid subjects. All studies were performed under controlled dietary conditions (35 and 45 kcal/kg body weight/day respectively for euthyroid and hyperthyroid subjects). In the post-absorptive state hyperthyroid patients had normal, glucagon levels and, in spite of increased insulinemia (p less than 0.02), elevated concentrations of blood glucose (p less than 0.01), glycerol (p less than 0.001) and ketone bodies (p less than 0.05). In the face of this hyperketonaemia, there was no significant increase of plasma FFA, suggesting possible increased hepatic conversion of FFA to ketone bodies. However, when FFA were acutely raised to high levels, the induced rise of ketone bodies was similar in hyperthyroid and euthyroid subjects. Oral propranolol administration to hyperthyroid patients in the post-absorptive state decreased the concentrations of glycerol (p less than 0.05) and ketone bodies (p less than 0.05) without altering insulin concentrations. Ketone bodies fell without any significant decrease of FFA suggesting a possible direct effect of propranolol administration on hepatic ketogenesis. However, the ketone body response to raised FFA levels was unaffected by propranolol. We have evidence in hyperthyroid patients of increased lipolysis and ketogenesis in spite of increased daily caloric intake. These results suggest that these metabolic abnormalities are not merely due to relative starvation. We have tentative evidence for modification of the intra-hepatic conversion of FFA to ketone bodies in the post-absorptive state but no supporting evidence when FFA levels were experimentally raised.

摘要

我们间接评估了游离脂肪酸(FFA)和肝脏生酮作用在甲状腺功能正常和甲状腺功能亢进受试者酮体水平调节中的作用。所有研究均在可控饮食条件下进行(甲状腺功能正常和甲状腺功能亢进受试者分别为35和45千卡/千克体重/天)。在吸收后状态下,甲状腺功能亢进患者的胰高血糖素水平正常,尽管胰岛素血症增加(p<0.02),但血糖(p<0.01)、甘油(p<0.001)和酮体浓度升高(p<0.05)。面对这种高酮血症,血浆FFA没有显著增加,提示FFA向酮体的肝脏转化率可能增加。然而,当FFA急性升高至高水平时,甲状腺功能亢进和甲状腺功能正常受试者中诱导的酮体升高相似。在吸收后状态下,给甲状腺功能亢进患者口服普萘洛尔可降低甘油(p<0.05)和酮体浓度(p<0.05),而不改变胰岛素浓度。酮体下降,但FFA没有显著降低,提示普萘洛尔给药可能对肝脏生酮有直接作用。然而,普萘洛尔不影响酮体对升高的FFA水平的反应。我们有证据表明,尽管每日热量摄入增加,但甲状腺功能亢进患者的脂肪分解和生酮作用增强。这些结果表明,这些代谢异常不仅仅是由于相对饥饿所致。我们有初步证据表明,在吸收后状态下,肝脏内FFA向酮体的转化发生了改变,但当FFA水平通过实验升高时,没有支持性证据。

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验